UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 553

Sortiert nach

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Blood, 2021-03, Vol.137 (11), p.1468-1477

2021

Volltextzugriff (PDF)

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

American journal of transplantation, 2005-12, Vol.5 (12), p.2901-2906

2005

Volltextzugriff (PDF)

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial

American journal of transplantation, 2015-04, Vol.15 (4), p.1091-1100

2015

Volltextzugriff (PDF)

CHOP-21 for the treatment of post-transplant lymphoproliferative disorders following solid organ transplantation

Haematologica (Roma), 2007-02, Vol.92 (2), p.273-274

2007

Volltextzugriff (PDF)

Radioimmunotherapy (90Y‐Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab

American journal of transplantation, 2015-07, Vol.15 (7), p.1976-1981

2015

Volltextzugriff (PDF)

Outcomes in patients with EBV+ PTLD treated with allogeneic EBV‐specific T‐cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe

Hematological oncology, 2023-06, Vol.41 (S2), p.523-524

2023

Volltextzugriff (PDF)

Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders

Annals of hematology, 2019-03, Vol.98 (3), p.625-632

2019

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

Annals of oncology, 2017-11, Vol.28 (11), p.2793-2798

2017

Volltextzugriff (PDF)

MECP2 Mutations in Sporadic Cases of Rett Syndrome Are Almost Exclusively of Paternal Origin

American journal of human genetics, 2001-05, Vol.68 (5), p.1093-1101

2001

Volltextzugriff (PDF)

P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF‐THE‐SHELF EBV‐SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES

HemaSphere, 2022-06, Vol.6 (Suppl), p.1339-1340

2022

Volltextzugriff (PDF)

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Leukemia, 2013-10, Vol.27 (10), p.2102-2105

2013

Volltextzugriff (PDF)

Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression

American journal of transplantation, 2009-10, Vol.9 (10), p.2331-2337

2009

Volltextzugriff (PDF)

P1107: CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+ PTLD WHO FAIL RITUXIMAB PLUS CHEMOTHERAPY: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.997-998

2022

Volltextzugriff (PDF)

Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO)

Thrombosis research, 2009-11, Vol.124 (5), p.531-535

2009

Volltextzugriff (PDF)

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab--monitoring of antiphospholipid and anti-GP antibodies: a case report

Annals of hematology, 2006-02, Vol.85 (2), p.134-135

2006

Volltextzugriff (PDF)

Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone

Annals of hematology, 2009-02, Vol.88 (2), p.167-172

2009

Volltextzugriff (PDF)

Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection

Transplant infectious disease, 2007-03, Vol.9 (1), p.42-45

2007

Volltextzugriff (PDF)

HIV-assoziierte Lymphome und Posttransplantationslymphome

Der Onkologe, 2006-07, Vol.12 (7), p.641-650

2006

Volltextzugriff (PDF)

Identification and characterization of NIF3L1 BP1, a novel cytoplasmic interaction partner of the NIF3L1 protein

Biochemical and biophysical research communications, 2003-09, Vol.309 (2), p.440-448

2003

Volltextzugriff (PDF)

Identification and characterization of a novel murine multigene family containing a PHD-finger-like motif

Biochemical and biophysical research communications, 2002-05, Vol.293 (2), p.816-826

2002

Volltextzugriff (PDF)

MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution

Journal of medical genetics, 2002-08, Vol.39 (8), p.586-588

2002

Volltextzugriff (PDF)

Diagnostische und therapeutische Eingriffe bei Patienten mit antithrombotischer Medikation: Was ist zu beachten?

Deutsche medizinische Wochenschrift, 2006-04, Vol.131 (17), p.982-986

2006

Volltextzugriff (PDF)

Partial trisomy of chromosome 22 resulting from an interstitial duplication of 22q11.2 in a child with typical cat eye syndrome

Journal of medical genetics, 2003-05, Vol.40 (5), p.e62-62

2003

Volltextzugriff (PDF)

The Caenorhabditis elegans ortholog of human PHF5a shows a muscle-specific expression domain and is essential for C. elegans morphogenetic development

Biochemical and biophysical research communications, 2002-10, Vol.297 (4), p.1049-1057

2002

Volltextzugriff (PDF)

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases

Haematologica (Roma), 2011-07, Vol.96 (7), p.1067-1071

2011

Volltextzugriff (PDF)

1 – 25 von 553

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(483)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(252)
Life Sciences & Biomedicine
(197)
Humans
(194)
Male
(139)
Adult
(109)
Female
(106)
Middle Aged
(95)
Biological And Medical Sciences
(85)
Aged
(74)
Fundamental And Applied Biological Sciences. Psychology
(50)
Cardiovascular System & Cardiology
(42)
Cardiac & Cardiovascular Systems
(41)
Medical Sciences
(41)
Physiology
(41)
Physical Sciences
(36)
Sport Sciences
(31)
Technology
(31)
Follow-Up Studies
(30)
Animals
(29)
Electrocardiography
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial

CHOP-21 for the treatment of post-transplant lymphoproliferative disorders following solid organ transplantation

Radioimmunotherapy (90Y‐Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab

Outcomes in patients with EBV+ PTLD treated with allogeneic EBV‐specific T‐cell immunotherapy (tabelecleucel) under an expanded access program (EAP) in Europe

Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

MECP2 Mutations in Sporadic Cases of Rett Syndrome Are Almost Exclusively of Paternal Origin

P1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF‐THE‐SHELF EBV‐SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Treatment of PTLD with Rituximab and CHOP Reduces the Risk of Renal Graft Impairment after Reduction of Immunosuppression

P1107: CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+ PTLD WHO FAIL RITUXIMAB PLUS CHEMOTHERAPY: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO)

Successful treatment of thrombocytopenia in primary antiphospholipid antibody syndrome with the anti-CD20 antibody rituximab--monitoring of antiphospholipid and anti-GP antibodies: a case report

Efficiency of antiviral therapy plus IVIG in a case of primary EBV infection associated PTLD refractory to rituximab, chemotherapy, and antiviral therapy alone

Acute esophageal necrosis (black esophagus) in the renal transplant recipient: manifestation of primary cytomegalovirus infection

HIV-assoziierte Lymphome und Posttransplantationslymphome

Identification and characterization of NIF3L1 BP1, a novel cytoplasmic interaction partner of the NIF3L1 protein

Identification and characterization of a novel murine multigene family containing a PHD-finger-like motif

MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution

Diagnostische und therapeutische Eingriffe bei Patienten mit antithrombotischer Medikation: Was ist zu beachten?

Partial trisomy of chromosome 22 resulting from an interstitial duplication of 22q11.2 in a child with typical cat eye syndrome

The Caenorhabditis elegans ortholog of human PHF5a shows a muscle-specific expression domain and is essential for C. elegans morphogenetic development

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases

Suchergebnisse filtern